Hyperhomocysteinaemia in Behçet's disease

Rheumatology

Volumn 40, Issue 6, 2001, Pages 687-690

  Aksu, K ^a,b   Turgan, N ^a   Oksel, F ^a   Keser, G ^a   Ozmen D ^a   Kitapcioglu G ^a   Gumusdis O ^a   Bayindir, G ^a   Doganavsargil E ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Beh et's disease; Homocysteine; Hyperhomocysteinaemia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; METHOTREXATE;

ADULT; AGE; AMINO ACID BLOOD LEVEL; ANAMNESIS; ARTERY THROMBOSIS; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DIET RESTRICTION; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SCREENING; STATISTICAL ANALYSIS; VEIN THROMBOSIS;

ADULT; BEHCET SYNDROME; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS;

EID: 0034943763     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Behçet's syndrome
2. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease
3. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study
4. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients
5. Increased plasma homocysteine concentration in patients with chronic renal failure
6. Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy
7. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?
8. The effects of vitamins B12, B6 and folate and blood homocysteine levels
9. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention
10. Plasma homocysteine levels in acute coronary syndromes
11. Plasma homocysteine in venous thrombo-embolism
12. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
13. Criteria for diagnosis of Behcet's disease
14. Three different methods for the determination of total homocysteine in plasma
15. Evidence for an endothelial cell dysfunction in association with Behçet's disease
16. Clinical relevance of elevated serum thrombo-modulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides
17. Behçet's syndrome associated with protein S deficiency
18. Extensive venous thrombosis in a case of Behçet's disease associated with heterozygous protein C deficiency
19. Arterial thrombosis leading to intestinal infarction in a patient with Behçet's disease associated with protein C deficiency
20. Coagulation and fibrinolytic activity in Behçet's disease
21. Relation between folate status, a common mutation in methylene-tetrahydrofolate reductase and plasma homocysteine concentrations
22. Hyperhomocyst(e)inemia-determining factors and treatment
23. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
24. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
25. Homocysteine and venous thromboembolism
26. Homocysteine and hemostasis: Pathogenic mechanisms predisposing to thrombosis